000 | 01977 a2200553 4500 | ||
---|---|---|---|
005 | 20250518005926.0 | ||
264 | 0 | _c20200402 | |
008 | 202004s 0 0 eng d | ||
022 | _a1432-198X | ||
024 | 7 |
_a10.1007/s00467-018-4145-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFujinaga, Shuichiro | |
245 | 0 | 0 |
_aLong-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome. _h[electronic resource] |
260 |
_bPediatric nephrology (Berlin, Germany) _c02 2019 |
||
300 |
_a353-357 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Intravenous |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 |
_aAgammaglobulinemia _xchemically induced |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aCyclosporine _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDrug Resistance _xdrug effects |
650 | 0 | 4 |
_aDrug Therapy, Combination _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGlucocorticoids _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aJapan |
650 | 0 | 4 |
_aLymphocyte Depletion _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNephrotic Syndrome _xdrug therapy |
650 | 0 | 4 |
_aNeutropenia _xchemically induced |
650 | 0 | 4 | _aPulse Therapy, Drug |
650 | 0 | 4 |
_aRemission Induction _xmethods |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aRituximab _xpharmacology |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aNishino, Tomohiko | |
700 | 1 | _aUmeda, Chisato | |
700 | 1 | _aTomii, Yuji | |
700 | 1 | _aWatanabe, Yoshitaka | |
700 | 1 | _aSakuraya, Koji | |
773 | 0 |
_tPediatric nephrology (Berlin, Germany) _gvol. 34 _gno. 2 _gp. 353-357 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00467-018-4145-6 _zAvailable from publisher's website |
999 |
_c29041633 _d29041633 |